Kemnay Advisory Services’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
VPM
VCM
NAMI
CC
Kemnay Advisory Services's LGND Position: Q1 2026 in Review
Kemnay Advisory Services increased its Ligand Pharmaceuticals (LGND) stake by 266% in Q1 2026, buying an estimated $23.1K and bringing the position to 161 shares worth $32.1K. The position accounts for 0.01% of the portfolio, ranked #416.
Kemnay Advisory Services first reported a position in LGND in Q4 2025 and has held it in 2 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Kemnay Advisory Services held 161 shares of Ligand Pharmaceuticals worth $32.1K as of Q1 2026.
- Kemnay Advisory Services bought 117 Ligand Pharmaceuticals shares in Q1 2026, an estimated $23.1K.
- Ligand Pharmaceuticals made up 0.01% of Kemnay Advisory Services's portfolio in Q1 2026, its #416 holding.
- Kemnay Advisory Services first reported a position in Ligand Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Kemnay Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.